Purple Panda Pharmaceuticals Inc.'s free cash flows (FCFs) are expected to grow at a constant long-term growth rate (gL) of 13% per year into the preferred stock is $75,000,000 and $41,666,667, respectively. Purple Panda has 4,500,000 shares of common stock outstanding, and its weighted average cost of capital (WACC) is 19%. had any nonoperating assets in its balance sheet. Oops, a more careful review of Purple Panda's balance sheet actually reports a $2,480,000 portfolio of marketabies Panda financial situation? Review the statements below and select those that accurately describe Purple Pandation apply. The intrinsic value of Purple Panda's common stock decreases with the inclusion of the company's marketable securities portfolio into the analysis. The intrinsic value of Purple Panda's common stock increa ses with the inclusion of the company's marketable securities portfolio into the analysis. The revised intrinsic value of Purple Panda's common stock is $11.66 per share. The greater the market value of the marketable securities portfolio, the smaller the company's total intrinsic (entity) value